Retrophin, Inc.
(NASDAQ : RTRX)

( )
RTRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.57%93.761.3%$988.46m
BIIBBiogen Inc.
-0.35%226.391.3%$918.49m
AMGNAmgen Inc.
-2.74%177.471.3%$453.25m
GILDGilead Sciences, Inc.
-0.47%62.950.9%$425.78m
ILMNIllumina, Inc.
0.11%319.033.5%$281.76m
REGNRegeneron Pharmaceuticals, Inc.
-2.81%333.342.6%$254.55m
VRTXVertex Pharmaceuticals Incorporated
0.71%168.161.9%$234.34m
ALXNAlexion Pharmaceuticals, Inc.
0.08%126.012.0%$171.81m
ONCESpark Therapeutics, Inc.
-0.08%110.6211.2%$168.65m
EXASExact Sciences Corporation
0.44%92.2125.3%$159.85m
SRPTSarepta Therapeutics, Inc.
-1.76%116.6414.7%$146.14m
AAgilent Technologies, Inc.
0.99%76.181.6%$127.24m
INCYIncyte Corporation
-0.48%73.962.5%$94.31m
IONSIonis Pharmaceuticals, Inc.
0.44%72.998.3%$92.09m
BMRNBioMarin Pharmaceutical Inc.
0.98%83.164.3%$89.34m

Company Profile

Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.